Evaluation of Lower Extremity Tissue Perfusion With Polarized Laser Light
NCT ID: NCT03046628
Last Updated: 2017-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2017-02-28
2018-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-Invasive Assessment of Wound Healing With Optical Methods
NCT00578604
Low-level Laser Therapy for the Treatment of Diabetic Foot Ulcer
NCT03788642
Low Level Laser Therapy and Expression of VEGF, NO, VEGFR-2, HIF-1α in Diabetic Foot Ulcers
NCT02452086
Helium-Neon Laser Therapy Versus Infrared Laser Therapy in Treating Patients With Diabetic Foot Ulcer
NCT03338517
The Effect of Combined 650 nm and Infrared Laser on Chronic Diabetic Foot Ulcer Surface Area:
NCT05517863
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
As the blood supply to the tissue is the most important healing of the tissue regardless of the type of intervention chosen (conservative treatment includes systemic antibiotics or surgical debridement), there is clear necessity for a non-invasive test with high reliably assessing tissue perfusion in patients with diabetic ulcers.
Recently, a new a method for assessing multiple features in vital tissues using polarised laser light was introduced. The technique is based on tracking temporal changes of reflected secondary speckles produced in the skin when being illuminated by a laser beam. Change in skin's temporal vibration profile is generated by time varied oxygen concentration caused these temporal changes. This technology of nanometer motion sensing allows, according to studies already carried out, monitoring parameters such as blood pressure, pulse rate and heart rhythm, glucose concentration in the blood substances and alcohol, oxygen saturation and intraocular pressure.
In this study the investigators will examine, non-invasively, the tissue around the lower limb ulcers of 30 diabetic patients, beginning with the TcPO2 examination followed by the polarised laser light and complementary metal-oxide semiconductor (CMOS) camera examination, and analysing the data in order to determine the ability of the latter method for assessing the tissue oxygen pressure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with diabetic feet ulcers
Each patient will be examined twice, first with TcPO2 (TCM400, Radiometer Medical ApS, Denmark) and then with a green laser (harmonic of continuous neodymium-doped yttrium aluminium garnet laser 532-nm wavelength and fast camera (PixelLink PLE531) system.
TcPO2
Green laser (at 532nm) and a fast camera
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TcPO2
Green laser (at 532nm) and a fast camera
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with acute infection on bony involvement
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bar-Ilan University, Israel
OTHER
Meir Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Meir Nyska, Prof.
Role: STUDY_DIRECTOR
Head of the orthopaedic department
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
LoGerfo FW, Coffman JD. Current concepts. Vascular and microvascular disease of the foot in diabetes. Implications for foot care. N Engl J Med. 1984 Dec 20;311(25):1615-9. doi: 10.1056/NEJM198412203112506. No abstract available.
Consensus development conference on diabetic foot wound care. 7-8 April 1999, Boston, MA. American Diabetes Association. Adv Wound Care. 1999 Sep;12(7):353-61. No abstract available.
Rayman G, Williams SA, Spencer PD, Smaje LH, Wise PH, Tooke JE. Impaired microvascular hyperaemic response to minor skin trauma in type I diabetes. Br Med J (Clin Res Ed). 1986 May 17;292(6531):1295-8. doi: 10.1136/bmj.292.6531.1295.
Schaper NC, Andros G, Apelqvist J, Bakker K, Lammer J, Lepantalo M, Mills JL, Reekers J, Shearman CP, Zierler RE, Hinchliffe RJ. Diagnosis and treatment of peripheral arterial disease in diabetic patients with a foot ulcer. A progress report of the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev. 2012 Feb;28 Suppl 1:218-24. doi: 10.1002/dmrr.2255.
Alexandrescu VA, Hubermont G, Philips Y, Guillaumie B, Ngongang C, Vandenbossche P, Azdad K, Ledent G, Horion J. Selective primary angioplasty following an angiosome model of reperfusion in the treatment of Wagner 1-4 diabetic foot lesions: practice in a multidisciplinary diabetic limb service. J Endovasc Ther. 2008 Oct;15(5):580-93. doi: 10.1583/08-2460.1.
Lukkari-Rautiarinen E, Lepantalo M, Pietila J. Reproducibility of skin blood flow, perfusion pressure and oxygen tension measurements in advanced lower limb ischaemia. Eur J Vasc Surg. 1989 Aug;3(4):345-50. doi: 10.1016/s0950-821x(89)80072-6.
Beiderman Y, Amsel AD, Tzadka Y, Fixler D, Mico V, Garcia J, Teicher M, Zalevsky Z. A microscope configuration for nanometer 3-D movement monitoring accuracy. Micron. 2011 Jun;42(4):366-75. doi: 10.1016/j.micron.2010.05.020. Epub 2010 Sep 19.
Zalevsky Z, Beiderman Y, Margalit I, Gingold S, Teicher M, Mico V, Garcia J. Simultaneous remote extraction of multiple speech sources and heart beats from secondary speckles pattern. Opt Express. 2009 Nov 23;17(24):21566-80. doi: 10.1364/OE.17.021566.
Beiderman Y, Horovitz I, Burshtein N, Teicher M, Garcia J, Mico V, Zalevsky Z. Remote estimation of blood pulse pressure via temporal tracking of reflected secondary speckles pattern. J Biomed Opt. 2010 Nov-Dec;15(6):061707. doi: 10.1117/1.3505008.
Beiderman Y, Blumenberg R, Rabani N, Teicher M, Garcia J, Mico V, Zalevsky Z. Demonstration of remote optical measurement configuration that correlates to glucose concentration in blood. Biomed Opt Express. 2011 Mar 14;2(4):858-70. doi: 10.1364/BOE.2.000858.
Ozana N, Arbel N, Beiderman Y, Mico V, Sanz M, Garcia J, Anand A, Javidi B, Epstein Y, Zalevsky Z. Improved noncontact optical sensor for detection of glucose concentration and indication of dehydration level. Biomed Opt Express. 2014 May 22;5(6):1926-40. doi: 10.1364/BOE.5.001926. eCollection 2014 Jun 1.
Margalit I, Beiderman Y, Skaat A, Rosenfeld E, Belkin M, Tornow RP, Mico V, Garcia J, Zalevsky Z. New method for remote and repeatable monitoring of intraocular pressure variations. J Biomed Opt. 2014 Feb;19(2):027002. doi: 10.1117/1.JBO.19.2.027002.
Golberg M, Fixler D, Shainberg A, Zlochiver S, Mico V, Garcia J, Beiderman Y, Zalevsky Z. Speckle-based configuration for simultaneous in vitro inspection of mechanical contractions of cardiac myocyte cells. J Biomed Opt. 2013 Oct;18(10):101310. doi: 10.1117/1.JBO.18.10.101310.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MMC1602-16CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.